Connection

CRISTY KU to Retina

This is a "connection" page, showing publications CRISTY KU has written about Retina.
Connection Strength

0.842
  1. The Role of ERK1/2 Activation in Sarpogrelate-Mediated Neuroprotection. Invest Ophthalmol Vis Sci. 2018 01 01; 59(1):462-471.
    View in: PubMed
    Score: 0.459
  2. Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome. Invest Ophthalmol Vis Sci. 2021 06 01; 62(7):27.
    View in: PubMed
    Score: 0.145
  3. Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist. PLoS One. 2016; 11(7):e0159776.
    View in: PubMed
    Score: 0.104
  4. Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4560-9.
    View in: PubMed
    Score: 0.096
  5. Inherited Retinal Disease Panels-Caveat Emptor-Truly Know Your Inherited Retinal Disease Panel. Retina. 2022 01 01; 42(1):1-3.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.